APC and metastatic melanoma: More recently, preclinical studies have demonstrated the effectiveness of CPP-linked vaccines in prophylactic vaccination against OVA-expressing EG7 tumors [64], as well as metastatic melanoma [65], combining CPP, antigen and adjuvant in unique vaccine constructs allowing for the spatial-temporal integration of antigen uptake and directed APC activation [66].